1. Commission for Orphan Medicinal Products (COMP) (2007) Press release of the September 2007 meeting (http://www.emea.europa.eu/pdfs/human/comp/42020707en.pdf)
2. Commission for Orphan Medicinal Products (COMP) (2005) COMP report to the commission in relation to article 10 of regulation 141/2000 on orphan medicinal products (http://www.emea.europa.eu/pdfs/human/comp/3521805en.pdf)
3. Commission of the European Communities (2006) Commission Staff Working Document on the experience acquired as a result of the application of Regulation (EC) No. 141/2000 on orphan medicinal products and account of the public health benefits obtained (http://www.ec.europa.eu/enterprise/pharmaceuticals/orphanmp/doc/orphan_en_06-2006.pdf)
4. Regulation (EC), No. 141/2000 of the European Parliament and of the Council of 16 December 1999 on Orphan Medicinal Products. Official Journal of The European Communities L18, 1–5
5. The Orphan Drug Act (1983) Public law, 97–141 (http://www.fda.gov/orphan/oda.htm)